Detection of recurrence sites using 18F-fluorocholine PET/CT in prostate cancer patients with PSA failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Detection of recurrence sites using 18F-fluorocholine PET/CT in prostate cancer patients with PSA failure

Published:2022-11 Issue: Volume: Page:
ISSN:2287-8882
Container-title:Prostate International
language:en
Short-container-title:Prostate International

Author:

Kim Dong-Yun,Lee Won Woo,Song Yoo Sung,Hong Sung Kyu,Byun Seok-Soo,Kim Jae-Sung^ORCID

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Epidemiology of prostate cancer in South Korea;Han;Prostate Int,2015

2. Trends in prostate cancer prevalence and radical prostatectomy rate according to age structural changes in South Korea between 2005 and 2015;Lee;Yonsei Med J,2019

3. Impact of the evolving United States Preventative Services Task Force policy statements on incidence and distribution of prostate cancer over 15 years in a statewide cancer registry;Jeong;Prostate Int,2021

4. Revisiting prostate cancer recurrence with PSMA PET: Atlas of typical and atypical patterns of spread;Barbosa;Radiographics,2019

5. Percent tumor volume vs American Joint Committee on Cancer staging system subclassification for predicting biochemical recurrence in patients with pathologic T2 prostate cancer;Choi;J Cancer Res Clin Oncol,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Review of the First 40 Cases of¹⁷⁷Lu-PSMA Therapy in the Treatment of Non-prostatic Cancer;Anticancer Research;2024-05-31

2. Prognostic Importance of Lymphovascular Invasion for Specific Subgroup of Patients with Prostate Cancer After Robot-Assisted Radical Prostatectomy (The MSUG94 Group);Annals of Surgical Oncology;2024-01-10

3. Prostate-specific antigen doubling time predicts the efficacy of site-directed therapy for oligoprogressive castration-resistant prostate cancer;Prostate International;2023-12

4. Predictors of Outcomes in Patients With Clinically Lymph Node Positive Prostate Cancer After Definitive Radiotherapy;In Vivo;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3